Josef A. Buchner

Josef A. Buchner

Auto-generated profile, based on publicly available information

Josef A. Buchner

Department of Radiation Oncology, TUM School of Medicine, TUM University Hospital rechts der Isar, Technical University of Munich, Munich, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2024 in Strahlentherapie und Onkologie
Verified
Journal Article
Open access
PDF file
AEAyhan Can Erdur
Ayhan Can Erdur
DRDaniel Rusche
Daniel Rusche
DSDaniel Scholz
Daniel Scholz
JKJohannes Kiechle
Johannes Kiechle
SFStefan Fischer
Stefan Fischer
JPJan Peeken
Jan Peeken
The rapid development of artificial intelligence (AI) has gained importance, with many tools already entering our daily lives. The medical field of radiation oncology is also subject to this development, with AI entering all steps of the patient journey. In this review article, we summarize contemporary AI techniques and explore the clinical applications of AI-based automated segmentation models in radiotherapy planning, focusing on delineation of organs at risk (OARs), the gross tumor volume (GTV), and the clinical target volume (CTV). Emphasizing the need for precise and individualized plans, we review various commercial and freeware segmentation tools and also state-of-the-art approaches. Through our own findings and based on the literature, we demonstrate improved efficiency and consistency as well as time savings in different clinical scenarios. Despite challenges in clinical implementation such as domain shifts, the potential benefits for personalized treatment planning are substantial. The integration of mathematical tumor growth models and AI-based tumor detection further enhances the possibilities for refining target volumes. As advancements continue, the prospect of one-stop-shop segmentation and radiotherapy planning represents an exciting frontier in radiotherapy, potentially enabling fast treatment with enhanced precision and individualization.

25 November 2022 in Radiotherapy and Oncology
Verified
Journal Article
Open access
JBJosef A. Buchner
Josef A. Buchner
FKFlorian Kofler
Florian Kofler
LELucas Etzel
Lucas Etzel
MMMichael Mayinger
Michael Mayinger
SCSebastian M. Christ
Sebastian M. Christ
JPJan C. Peeken
Jan C. Peeken
Stereotactic radiotherapy is a standard treatment option for patients with brain metastases. The planning target volume is based on gross tumor volume (GTV) segmentation. The aim of this work is to develop and validate a neural network for automatic GTV segmentation to accelerate clinical daily routine practice and minimize interobserver variability. We analyzed MRIs (T1-weighted sequence ± contrast-enhancement, T2-weighted sequence, and FLAIR sequence) from 348 patients with at least one brain metastasis from different cancer primaries treated in six centers. To generate reference segmentations, all GTVs and the FLAIR hyperintense edematous regions were segmented manually. A 3D-U-Net was trained on a cohort of 260 patients from two centers to segment the GTV and the surrounding FLAIR hyperintense region. During training varying degrees of data augmentation were applied. Model validation was performed using an independent international multicenter test cohort (n = 88) including four centers. Our proposed U-Net reached a mean overall Dice similarity coefficient (DSC) of 0.92 ± 0.08 and a mean individual metastasis-wise DSC of 0.89 ± 0.11 in the external test cohort for GTV segmentation. Data augmentation improved the segmentation performance significantly. Detection of brain metastases was effective with a mean F1-Score of 0.93 ± 0.16. The model performance was stable independent of the center (p = 0.3). There was no correlation between metastasis volume and DSC (Pearson correlation coefficient 0.07). Reliable automated segmentation of brain metastases with neural networks is possible and may support radiotherapy planning by providing more objective GTV definitions.

30 May 2024 in Neuro-Oncology
Verified
Journal Article
Open access
PDF file
JBJosef A Buchner
Josef A Buchner
FKFlorian Kofler
Florian Kofler
MMMichael Mayinger
Michael Mayinger
SCSebastian M Christ
Sebastian M Christ
TBThomas B Brunner
Thomas B Brunner
JPJan C Peeken
Jan C Peeken
Surgical resection is the standard of care for patients with large or symptomatic brain metastases (BMs). Despite improved local control after adjuvant stereotactic radiotherapy, the risk of local failure (LF) persists. Therefore, we aimed to develop and externally validate a pre-therapeutic radiomics-based prediction tool to identify patients at high LF risk. Data were collected from A Multicenter Analysis of Stereotactic Radiotherapy to the Resection Cavity of Brain Metastases (AURORA) retrospective study (training cohort: 253 patients from two centers; external test cohort: 99 patients from five centers). Radiomic features were extracted from the contrast-enhancing BM (T1-CE MRI sequence) and the surrounding edema (FLAIR sequence). Different combinations of radiomic and clinical features were compared. The final models were trained on the entire training cohort with the best parameter set previously determined by internal 5-fold cross-validation and tested on the external test set. The best performance in the external test was achieved by an elastic net regression model trained with a combination of radiomic and clinical features with a concordance index (CI) of 0.77, outperforming any clinical model (best CI: 0.70). The model effectively stratified patients by LF risk in a Kaplan-Meier analysis (p < 0.001) and demonstrated an incremental net clinical benefit. At 24 months, we found LF in 9% and 74% of the low and high-risk groups, respectively. A combination of clinical and radiomic features predicted freedom from LF better than any clinical feature set alone. Patients at high risk for LF may benefit from stricter follow-up routines or intensified therapy.

7 September 2023 in Radiotherapy and Oncology
Verified
Journal Article
Open access
JBJosef A Buchner
Josef A Buchner
JPJan C Peeken
Jan C Peeken
LELucas Etzel
Lucas Etzel
IEIvan Ezhov
Ivan Ezhov
MMMichael Mayinger
Michael Mayinger
FKFlorian Kofler
Florian Kofler
Many automatic approaches to brain tumor segmentation employ multiple magnetic resonance imaging (MRI) sequences. The goal of this project was to compare different combinations of input sequences to determine which MRI sequences are needed for effective automated brain metastasis (BM) segmentation. We analyzed preoperative imaging (T1-weighted sequence ± contrast-enhancement (T1/T1-CE), T2-weighted sequence (T2), and T2 fluid-attenuated inversion recovery (T2-FLAIR) sequence) from 339 patients with BMs from seven centers. A baseline 3D U-Net with all four sequences and six U-Nets with plausible sequence combinations (T1-CE, T1, T2-FLAIR, T1-CE + T2-FLAIR, T1-CE + T1 + T2-FLAIR, T1-CE + T1) were trained on 239 patients from two centers and subsequently tested on an external cohort of 100 patients from five centers. The model based on T1-CE alone achieved the best segmentation performance for BM segmentation with a median Dice similarity coefficient (DSC) of 0.96. Models trained without T1-CE performed worse (T1-only: DSC = 0.70 and T2-FLAIR-only: DSC = 0.73). For edema segmentation, models that included both T1-CE and T2-FLAIR performed best (DSC = 0.93), while the remaining four models without simultaneous inclusion of these both sequences reached a median DSC of 0.81-0.89. A T1-CE-only protocol suffices for the segmentation of BMs. The combination of T1-CE and T2-FLAIR is important for edema segmentation. Missing either T1-CE or T2-FLAIR decreases performance. These findings may improve imaging routines by omitting unnecessary sequences, thus allowing for faster procedures in daily clinical practice while enabling optimal neural network-based target definitions.

14 November 2025 in medRxiv
Verified
Preprint
Open access
PDF file
JCJulian Canisius
Julian Canisius
JBJosef Buchner
Josef Buchner
MRMarcel Rosier
Marcel Rosier
MGMichael Griessmair
Michael Griessmair
JPJan Peeken
Jan Peeken
FKFlorian Kofler
Florian Kofler
Background: Precise glioma segmentation in MRI is essential for accurate diagnosis, optimal treatment planning, and advancing clinical research. However, most deep learning approaches require complete, standardized MRI protocols that are frequently unavailable in routine clinical practice. This study presents and evaluates GlioMODA, a robust deep learning framework designed for automated glioma segmentation that delivers consistent high performance across varied and incomplete MRI protocols. Methods: GlioMODA was trained and validated on the BraTS 2021 dataset (1,251 training, 219 testing cases), systematically assessing performance across eleven clinically relevant MRI protocol combinations. Segmentation accuracy was evaluated using Dice similarity coefficients (DSC) and panoptic quality metrics. Volumetric accuracy was benchmarked against manual ground truth, and statistical significance was established via Wilcoxon signed-rank tests with Benjamini–Yekutieli correction. Results: GlioMODA demonstrated state-of-the-art segmentation accuracy across tumor subregions, maintaining robust performance with incomplete or heterogeneous MRI protocols. Protocols including both T1-weighted contrast-enhanced and T2-FLAIR sequences yielded volumetric differences versus manual ground truth that were not statistically significant for enhancing tumor (ET: median difference 55 mm³, p = 0.157) and whole tumor (WT: median difference –7 mm³, p = 1.0), and exhibited median DSC differences close to zero relative to the four-sequence reference protocol. Omitting either sequence led to substantial and significant volumetric errors. Conclusions: GlioMODA facilitates reliable, automated glioma segmentation using a streamlined two-sequence protocol (T1-contrast + T2-FLAIR), supporting clinical workflow optimization and broader implementation of quantitative volumetry compatible with RANO 2.0 criteria. GlioMODA is published as an open-source, easy-to-use Python package at https://github.com/BrainLesion/GlioMODA/ . Key Points: T1-CE + T2-FLAIR maintains enhancing and whole tumor segmentation comparable to four-sequence MRI. Consistent volumes with T1-CE + T2-FLAIR support reliable RANO 2.0 assessment. Open-source GlioMODA (models + code) supports rapid integration. Importance of the Study: Automated glioma segmentation is limited in practice by incomplete or heterogeneous MRI protocols. GlioMODA directly addresses this barrier by delivering consistent accuracy across 11 clinically relevant sequence combinations and identifying a streamlined protocol (T1-contrast and T2-FLAIR) whose enhancing- and whole-tumor volumes are not statistically different from expert reference. This enables shorter scans and reproducible volumetry compatible with RANO 2.0, facilitating reliable response assessment in trials and routine care. By releasing trained models and code as an easy-to-use open-source package, this work enables external validation and integration into neuro-oncology workflows.

2 May 2023 in medRxiv
Verified
Preprint
Open access
PDF file
JBJosef A Buchner
Josef A Buchner
JPJan C Peeken
Jan C Peeken
LELucas Etzel
Lucas Etzel
IEIvan Ezhov
Ivan Ezhov
MMMichael Mayinger
Michael Mayinger
FKFlorian Kofler
Florian Kofler
Background Many automatic approaches to brain tumor segmentation employ multiple magnetic resonance imaging (MRI) sequences. The goal of this project was to compare different combinations of input sequences to determine which MRI sequences are needed for effective automated brain metastasis (BM) segmentation. Methods We analyzed preoperative imaging (T1-weighted sequence ± contrast-enhancement (T1/T1-CE), T2-weighted sequence (T2), and T2 fluid-attenuated inversion recovery (T2-FLAIR) sequence) from 333 patients with BMs from six centers. A baseline 3D U-Net with all four sequences and six U-Nets with plausible sequence combinations (T1-CE, T1, T2-FLAIR, T1-CE+T2-FLAIR, T1-CE+T1+T2-FLAIR, T1-CE+T1) were trained on 239 patients from two centers and subsequently tested on an external cohort of 94 patients from four centers. Results The model based on T1-CE alone achieved the best segmentation performance for BM segmentation with a median Dice similarity coefficient (DSC) of 0.96. Models trained without T1-CE performed worse (T1-only: DSC = 0.70 and T2-FLAIR-only: DSC = 0.72). For edema segmentation, models that included both T1-CE and T2-FLAIR performed best (DSC = 0.93), while the remaining four models without simultaneous inclusion of these both sequences reached a median DSC of 0.81-0.89. Conclusions A T1-CE-only protocol suffices for the segmentation of BMs. The combination of T1-CE and T2-FLAIR is important for edema segmentation. Missing either T1-CE or T2-FLAIR decreases performance. These findings may improve imaging routines by omitting unnecessary sequences, thus allowing for faster procedures in daily clinical practice while enabling optimal neural network-based target definitions.